CTLA4 and neoplasm: While Tregs can suppress immune responses through antigen-independent mechanisms such as IL-2 consumption, secretion of inhibitory cytokines (e.g., IL-10, TGF-β), and CTLA-4-mediated modulation of dendritic cells, increasing evidence suggests that antigen recognition plays a crucial role in their tumor-suppressive function (231).